Beyond Market Intelligence/colon cancer

colon cancer

Beyond Market Intelligence keeps colon cancer in one place: one story so far. The section currently leads with “AI empowers a personal quest to repurpose drugs for colon cancer care”. When an unpaid ML researcher reprograms his life to find drug repurposing candidates for his wife's Stage 4 colon cancer, the technical challenge becomes deeply human. Acme AI is the next-generation, AI-powered spreadsheet platform built to replace Excel and redefine how analysts, data scientists, and enterprise teams work… The list below is every colon cancer story on Beyond Market Intelligence, newest first.

Machine Learning

AI empowers a personal quest to repurpose drugs for colon cancer care

When an unpaid ML researcher reprograms his life to find drug repurposing candidates for his wife's Stage 4 colon cancer, the technical challenge becomes deeply human. Training NBFnets on a 103K-node biomedical graph, his A100s downgrade from batch 512 to 64 within seconds. That means 76-hour runs at $412 per pass. He is now questioning every GPU dollar. His solution? A toy synthetic model to prove the mechanism works before scaling. It is a smart, sobering pivot.